HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China.

AbstractBACKGROUND:
To evaluate the association between the genetic polymorphism of the solute carrier organic anion transporter family member 1B1 (SLCO1B1, also known as organic anion transport polypeptide C) and hyperbilirubinemia in Chinese neonates.
METHODS:
183 infants with hyperbilirubinemia and 192 control subjects from the Fifth People's Hospital of Shenzhen were recruited. Polymerase chain reaction, restriction fragment length polymorphisms and agarose gel electrophoresis techniques were used to detect genetic variants of SLCO1B1.
RESULTS:
The study revealed that SLCO1B1 388 G > A occurred significantly more frequently in neonates with hyperbilirubinemia than in controls (RR = 1.50; 95% CI: 1.13-2.00). There were no significant differences in SLCO1B1 521 T > C between the hyperbilirubinemia and the control group (RR, 1.00; 95% CI, 0.72-1.40). No carriage of the C to A substitution at nucleotide 463 was detected.
CONCLUSION:
The SLCO1B1 388 G > A variant is associated with neonatal hyperbilirubinemia in Chinese neonates.
AuthorsJiebo Liu, Jun Long, Shaofang Zhang, Xiaoyan Fang, Yuyuan Luo
JournalItalian journal of pediatrics (Ital J Pediatr) Vol. 39 Pg. 49 (Aug 12 2013) ISSN: 1824-7288 [Electronic] England
PMID24090270 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Liver-Specific Organic Anion Transporter 1
  • Organic Anion Transporters
  • SLCO1B1 protein, human
Topics
  • Alleles
  • Case-Control Studies
  • Chi-Square Distribution
  • China
  • Female
  • Genetic Predisposition to Disease (epidemiology)
  • Genotype
  • Humans
  • Hyperbilirubinemia, Neonatal (genetics)
  • Infant, Newborn
  • Liver-Specific Organic Anion Transporter 1
  • Male
  • Organic Anion Transporters (genetics)
  • Polymorphism, Genetic
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: